Cedars-Sinai Names Mia Miller, MD, to Lead Otolaryngology Division
Neurotologist and skull base surgeon Mia E. Miller, MD, plans to expand subspecialty training and launch a hearing regeneration research lab.
Read MoreNeurotologist and skull base surgeon Mia E. Miller, MD, plans to expand subspecialty training and launch a hearing regeneration research lab.
Read MoreA federal court has issued a preliminary injunction halting the Department of Education’s narrowed definition of “professional degree,” temporarily restoring higher federal borrowing limits for Doctor of Audiology students.
Read MoreOticon is accepting nominations for its annual awards program recognizing individuals with hearing loss and the professionals, caregivers, and educators who champion hearing health.
Read MoreIsraeli and US researchers have identified a biological mechanism that prompts supporting cells in the inner ear to regenerate into sensory hair cells.
Read MoreMed-El has acquired two gene therapy programs from Rescue Hearing Inc targeting mutations in the MYO7A and STRC genes, expanding the hearing implant company’s pipeline into biological approaches to vestibular and auditory dysfunction.
Read MoreThe biotech secures improved royalty terms on its two lead hearing loss programs, CIL001 and CIL003, while Sanofi takes a minority stake in the company.
Read MoreThe FCC-certified captioning app’s AI-powered TTS features earned the company the “Text to Speech Solution of the Year” recognition in the ninth annual AI Breakthrough Awards program.
Read MoreMore than 100 Oticon employees joined Community Hope’s 2026 Flag Day 5K and Fun Walk, marking the largest team turnout in the event’s history for the hearing healthcare company.
Read MorePoll data from ASHA’s campaign shows audiologist and SLP intervention significantly improves outcomes for patients and their caregivers.
Read MoreA new TruHearing survey finds that nearly half of Tennessee seniors with hearing loss cite cost as the reason they have not pursued treatment, with many waiting more than five years before seeking care.
Read MoreThe OTC hearing brand known for its affordable hearing aids is entering the hearing preservation space with an audiologist-developed device designed to reduce harmful noise exposure without sacrificing sound quality.
Read MoreA new study published in PLOS One offers what researchers say is the most evidence-supported explanation yet for “The Hum” — an unexplained low-frequency droning reported by people around the world.
Read MoreThe Eden Prairie-based hearing technology company’s latest recognition is based entirely on employee feedback and follows a string of workplace and culture awards in recent years.
Read MoreThe national hearing care company, part of the Demant Group, continues expanding its community-level footprint with a new location in Northern Virginia.
Read MoreThe ProHear Study found that the drug candidate Bimokalner produced a clinically meaningful reduction in pure-tone audiometry threshold shifts in testicular cancer patients who developed cisplatin-induced ototoxicity.
Read More